Sleep Aids (Pharmacies) - Czechia

Revenue in the Sleep Aids market is projected to reach US$2.61m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 0.51%, resulting in a market volume of US$2.67m by 2029.
In global comparison, most revenue will be generated United States (US$1.47bn in 2024).
In relation to total population figures, per person revenues of US$0.25 are generated in 2024.

Definition:
The Sleep Aids market encompasses a diverse array of over-the-counter (OTC) medications and supplements designed to aid individuals in managing sleep-related disorders, including insomnia, sporadic sleep disruptions, and jetlag resulting from adjusting to different time zones. This market includes products containing ingredients such as Doxylamine Succinate, Diphenhydramine, Melatonin, and herbal remedies. Notable sleep aid products include Natrol Melatonin, Vitafusion, Alteril, Unisom SleepTabs, and Kalms. This market exclusively covers product sales through pharmacies.

Additional information:
The Sleep Aids market comprises revenues, average revenue per capita and average revenue per pharmacy. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Single Active Ingredient Formulations
Combination Active Ingredient Formulations
Herbal Remedies
Melatonin Products

Prescription Sleep Medications
Products for Chronic Insomnia which are not designed to address only occasional sleep challenges

The Sleep Aids (Pharmacies) market in Czechia has been experiencing steady growth in recent years.

Customer preferences: Customers in Czechia are increasingly seeking sleep aids to address their sleep-related issues. This can be attributed to various factors such as the growing awareness about the importance of sleep for overall health and well-being, as well as the rising prevalence of sleep disorders in the country. Sleep aids are seen as a convenient and accessible solution for those struggling with sleep problems.

Trends in the market: One of the key trends in the Sleep Aids (Pharmacies) market in Czechia is the increasing demand for natural and herbal sleep aids. Customers are becoming more conscious about the ingredients and potential side effects of sleep aids, leading them to opt for products that are perceived as safer and more natural. This trend is in line with the global shift towards natural and organic products in the healthcare industry. Another trend in the market is the growing popularity of over-the-counter (OTC) sleep aids. Customers are increasingly turning to OTC products as they offer convenience and affordability compared to prescription sleep aids. The ease of accessibility and the ability to purchase these products without a prescription make them a preferred choice for many consumers.

Local special circumstances: Czechia has a well-established healthcare system with a strong emphasis on pharmaceuticals. Pharmacies play a crucial role in the distribution of sleep aids, making them easily accessible to the general public. The presence of a large number of pharmacies across the country ensures that customers have convenient access to a wide range of sleep aids.

Underlying macroeconomic factors: The growing demand for sleep aids in Czechia can be attributed to several underlying macroeconomic factors. The country has been experiencing steady economic growth, leading to an increase in disposable income among the population. This has resulted in higher healthcare spending, including the purchase of sleep aids. Furthermore, the aging population in Czechia is also contributing to the growth of the Sleep Aids (Pharmacies) market. As people age, they are more likely to experience sleep-related issues, leading to a higher demand for sleep aids. The increasing life expectancy in the country is expected to further drive the demand for sleep aids in the coming years. In conclusion, the Sleep Aids (Pharmacies) market in Czechia is witnessing growth due to the increasing customer preference for sleep aids, the popularity of natural and OTC products, the accessibility of pharmacies, and the underlying macroeconomic factors such as economic growth and an aging population.

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global online pharmacy sector was estimated at 32 billion U.S. dollars by the end of 2023. In the United States, forecasts indicate that this figure would reach approximately 5.7 billion, solidifying its position as one of the largest online pharmacy markets. However, China dominates the pharma e-commerce industry worldwide, generating nearly 8.5 billion dollars in revenue. With China at the forefront, it is no wonder digital pharmacies make up the fastest-growing segment in the Asian digital health market.